interleukin-4 PE38KDEL cytotoxin

BIOLOGICAL3 trials

Sponsors

Barrett Cancer Center, Neurocrine Biosciences

Conditions

Brain and Central Nervous System TumorsBreast CancerKidney CancerLung Cancer

Phase 1

Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer

CompletedNCT00039052

Neurocrine BiosciencesBreast Cancer, Kidney Cancer, Lung Cancer

Start: 2002-01-31End: 2008-07-31Updated: 2013-07-18

IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma

Barrett Cancer CenterBrain and Central Nervous System Tumors

Start: 1999-03-31Target: 30Updated: 2013-12-18

Phase 2

NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme

CompletedNCT00014677

Neurocrine BiosciencesBrain and Central Nervous System Tumors

Start: 2001-03-31End: 2008-07-31Updated: 2013-07-18